Ferritinemia reflects macrophage activation and the IL-1β/IL-18 signaling pathway and is a reliable HLH biomarker for disease follow-up and monitoring, although the 500 μg/L threshold currently used has been shown to have poor sensitivity and specificity in the ICU (36, 43–46). This evidence concerns the gene IL1B and hemophagocytic syndrome.